Texas grants for Small businesses

The Water Resources Preservation Grant Program, funded by the Upper Guadalupe River Authority (UGRA), provides cost-share funding to support the design and construction of stormwater management practices. These practices, referred to as Best Management Practices (BMPs), include Low Impact Development (LID), nature-based solutions, and Green Stormwater Infrastructure (GSI). The goal is to reduce, infiltrate, filter, and delay stormwater runoff, thus protecting the health of waterways in Kerr County. Eligible projects can apply for rebates that cover a portion of the costs associated with these practices, with the aim of reducing pollutants like Total Suspended Solids (TSS) and Bacteria by significant percentages. The program supports new constructions or retrofits, emphasizes distributed and centralized treatment methods, and requires adherence to specific design guidelines.

This award mechanism seeks to support the delivery of evidence-based clinical services to screen for cancer and pre-cancer in underserved populations who do not have adequate access to cancer early detection interventions and health care, bringing together networks of public health and community partners to carry out programs tailored for their communities. Projects should identify cancers that cause the most burden in the community, have nationally recommended screening methods, and use evidence-based methods to screen for these cancers. Award: Maximum of $1M for new projects and $2.5M for expansion projects Duration: Maximum 5 years

Funding available through this RFA supports company formation, as well as early research and development of novel oncology therapeutics, devices, treatment-oriented information technology products, diagnostics, or tools. The objective of the SEED Award program is to start with an interesting technology and to progress it toward a commercially viable business opportunity, i.e., make it more attractive to private funding agents. Typically, applicants have completed the following activities: Identified a novel therapeutic, diagnostic technology, or clinical tool and shown a biological effect Conducted preliminary safety and toxicology testing (in the case of therapeutic agents) Shown the product can be manufactured at small scale or as a prototype Assessed the business opportunity and organized a business plan that begins to address key issues (clinical utility, target market, financial plan, IP strategy, technical challenges, etc.) and lays out a preliminary development plan (formulation, toxicology, scale up, IND-enabling studies, phase 1 clinical trials, regulatory pathway, etc.). Established a company

Funding available through this RFA supports the ongoing research and development of diagnostic tests and devices to treat, detect, diagnose, monitor, and assist in the treatment of cancer. Relevant areas include: Devices and assays for cancer detection, diagnosis, prognosis, monitoring, treatment and prediction of response or resistance to treatment Markers for cancer prevention and control, companion diagnostic to a therapy Development of diagnostic tests to distinguish high-risk early lesions Generally, at the time that an applicant applies to CPRIT pursuant to this RFA, the company has developed a commercial prototype of the device or a pictorial representation of the functional components/elements of the device. With respect to diagnostics, the company has developed assays that work on human samples and whose importance is well justified for development into clinical assays. The applicant should be working toward submitting an Investigational Device Exemption (IDE) or a 510(k) or Premarketing Approval (PMA) and is typically within one year from filing an IDE (or later stage work.) Potential applicants that are not at or near this stage of product development should consider applying for a Texas Seed Company Award. With appropriate justification, companies may use CPRIT funds to support studies that establish preclinical proof of concept, product validation, design, production, manufacturing and development, and clinical studies demonstrating safety and efficacy.

Funding available through this RFA supports the ongoing research and development of innovative products, services, and infrastructure with significant potential impact on patient care. Generally, at this stage, the company has identified and characterized a lead compound; demonstrated efficacy in multiple translationally relevant animal models; completed pilot/dose ranging toxicology studies; determined the feasibility of a scalable, GMP compliant manufacturing process, including release assays; and identified a prototype formulation suitable for further development. The applicant is typically within one year from filing an IND/IDE or already in Phase 1. With appropriate justification, companies may use CPRIT funds to support the following: Studies that establish preclinical proof of concept (safety and efficacy) CMC/manufacturing development GLP safety studies to support INDs Phase 1 in humans to establish safety and a recommended dose for phase 2 Phase 2 studies to determine safety and efficacy in initial targeted patient population

Funding available through this RFA supports the ongoing research and development of new and emerging technologies for the detection, diagnosis, prognosis, monitoring, or treatment of cancer. CPRIT created this RFA to fund new and emerging technology projects that do not easily fit into any of the three other CPRIT Product Development Research RFAs. Proposals may include, but are not limited to, bioinformatics, artificial intelligence, production of radionuclides or their precursors, manufacture of cell-based therapies, processes to improve the quality of the samples used for cancer research or clinical care, and biomanufacturing of therapeutics. With appropriate justification, companies may use CPRIT funds to support studies that establish preclinical proof of concept, product validation, design, production, manufacturing and development, and clinical studies demonstrating safety and efficacy.

This program provides financial assistance to commercial businesses in Liberty for exterior improvements that enhance the aesthetic appeal and promote business development within the city.

This program provides financial assistance to small business owners in Texas to help cover costs for training, memberships, and necessary licensing fees to enhance their business operations.

The City of Killeen Small Business Relief Program, funded through the American Rescue Plan Act, provides financial assistance to small businesses in Killeen that experienced financial hardships due to the coronavirus pandemic. The program aims to stabilize these businesses and mitigate additional adverse economic impacts. Small businesses can request up to $10,000. Applications opened on February 1, 2022, and will remain open until funds are fully allocated. Eligible businesses must be operational prior to March 2020, operate from a retail storefront within Killeen, have 50 or fewer employees, and have experienced a loss of income due to COVID-19.

This program provides financial support to local businesses in Helotes, Texas, to help them establish or enhance their online sales presence through matching grants for e-commerce marketing initiatives.

City of San Marcos Minority Business Stabilization Fund (Texas) - The City of San Marcos is offering minority entrepreneurs and small business owners within corporate city limits the opportunity to apply for the Minority Business Stabilization Fund Program. This one-time grant assistance program, funded through the American Rescue Plan Act (ARPA), provides direct aid to minority-owned businesses in San Marcos. Grant amounts range from $1,000 to $10,000 based on the number of full-time employees and can be used for eligible expenses such as physical improvements, equipment, e-commerce expansion costs, rent, payroll, and operating expenses. To be eligible, businesses must have been in operation in San Marcos for at least 12 months, employ 1 to 25 full-time employees, and be at least 51% unconditionally owned by a socially disadvantaged individual. Only one grant may be awarded per business with multiple locations in San Marcos. For more information and to apply, visit City of San Marcos website.

The Texas Department of Agriculture (TDA) is offering the PRODUCT PROMOTION (GTP) Grants as part of the GO TEXAN - Marketing Enhancement Grant Assistance Program. This initiative is specifically designed to support GO TEXAN Product Partners at Tier 2 or higher in their efforts to market and promote Texas products that are produced, processed, or have added value within the state. The grants aim to enhance the marketing capabilities of local businesses, fostering growth and expanding the reach of Texas products both locally and beyond. Applications are accepted until May 16, 2024, with the grant program running from August 15, 2024, through December 31, 2025. Eligible partners must be in good standing with the GO TEXAN program and meet specific participation criteria, including maintaining their partnership status throughout the grant period.

The Texas Department of Agriculture (TDA) offers the GO TEXAN - Event Grants as part of the Marketing Enhancement Grant Assistance Program. These grants aim to support Associate-level GO TEXAN partners who organize public events such as festivals and farmers markets, promoting Texas-made products and businesses under the GO TEXAN program. Eligible events must focus on advertising expenses and can only include one event per applicant within the designated timeline. Applications are accepted until May 16, 2024, and the projects can run from October 1, 2024, to December 31, 2025. Grant awards are determined based on the event’s adherence to GO TEXAN participation and program recognition, with funding available up to $20,000 depending on past participation and the extent of promotional activities.